LifePoint Health Inc (LPNT) Receives $65.33 Average Target Price from Brokerages

LifePoint Health Inc (NASDAQ:LPNT) has received an average recommendation of “Hold” from the seventeen research firms that are covering the company. Three research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $65.33.

A number of equities research analysts have recently weighed in on the company. TheStreet raised LifePoint Health from a “c+” rating to a “b-” rating in a research note on Monday, March 13th. Zacks Investment Research raised LifePoint Health from a “sell” rating to a “hold” rating in a research note on Wednesday, February 22nd. Cantor Fitzgerald reissued a “neutral” rating on shares of LifePoint Health in a research note on Tuesday, February 21st. Mizuho boosted their target price on LifePoint Health from $50.00 to $57.00 and gave the company a “neutral” rating in a research note on Tuesday, February 21st. Finally, Piper Jaffray Companies assumed coverage on LifePoint Health in a research note on Wednesday, January 4th. They issued a “neutral” rating and a $62.00 target price for the company.

LifePoint Health (NASDAQ:LPNT) opened at 60.85 on Thursday. LifePoint Health has a 12 month low of $50.60 and a 12 month high of $75.70. The stock has a market cap of $2.43 billion, a PE ratio of 21.58 and a beta of 0.87. The company’s 50 day moving average price is $62.56 and its 200 day moving average price is $59.29.

LifePoint Health (NASDAQ:LPNT) last released its earnings results on Friday, February 17th. The company reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.02. LifePoint Health had a return on equity of 7.02% and a net margin of 1.93%. The company earned $1.61 billion during the quarter, compared to analyst estimates of $1.63 billion. During the same quarter in the previous year, the company posted $1.11 EPS. LifePoint Health’s revenue for the quarter was up 17.1% on a year-over-year basis. Equities analysts forecast that LifePoint Health will post $4.18 EPS for the current fiscal year.

Your IP Address:

In other news, insider David M. Dill sold 18,800 shares of the stock in a transaction that occurred on Thursday, March 16th. The stock was sold at an average price of $62.22, for a total value of $1,169,736.00. Following the completion of the transaction, the insider now owns 207,873 shares of the company’s stock, valued at approximately $12,933,858.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP John P. Bumpus sold 26,362 shares of the stock in a transaction that occurred on Thursday, March 9th. The stock was sold at an average price of $65.05, for a total value of $1,714,848.10. Following the completion of the transaction, the executive vice president now directly owns 117,458 shares of the company’s stock, valued at approximately $7,640,642.90. The disclosure for this sale can be found here. Insiders have sold a total of 46,667 shares of company stock valued at $2,982,409 in the last ninety days. 7.28% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Diamond Hill Capital Management Inc. raised its position in shares of LifePoint Health by 11.7% in the third quarter. Diamond Hill Capital Management Inc. now owns 1,884,153 shares of the company’s stock valued at $111,598,000 after buying an additional 197,892 shares in the last quarter. BlackRock Fund Advisors raised its position in shares of LifePoint Health by 2.0% in the third quarter. BlackRock Fund Advisors now owns 1,671,550 shares of the company’s stock valued at $99,006,000 after buying an additional 32,566 shares in the last quarter. Letko Brosseau & Associates Inc. raised its position in shares of LifePoint Health by 38.1% in the fourth quarter. Letko Brosseau & Associates Inc. now owns 1,386,589 shares of the company’s stock valued at $78,758,000 after buying an additional 382,785 shares in the last quarter. Prudential PLC raised its position in shares of LifePoint Health by 36.6% in the fourth quarter. Prudential PLC now owns 586,900 shares of the company’s stock valued at $33,336,000 after buying an additional 157,400 shares in the last quarter. Finally, Schroder Investment Management Group raised its position in shares of LifePoint Health by 1.2% in the third quarter. Schroder Investment Management Group now owns 522,130 shares of the company’s stock valued at $30,926,000 after buying an additional 6,030 shares in the last quarter. 99.88% of the stock is owned by hedge funds and other institutional investors.

About LifePoint Health

LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.

5 Day Chart for NASDAQ:LPNT

Receive News & Ratings for LifePoint Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nike Suspends Relationship with Maria Sharapova
Nike Suspends Relationship with Maria Sharapova
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Ron Washington Leaves Texas Rangers Due to an Affair
Ron Washington Leaves Texas Rangers Due to an Affair
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Tony Stewart Case Going to the Grand Jury
Tony Stewart Case Going to the Grand Jury
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder


Leave a Reply

 
© 2006-2017 Web Breaking News.